2.2 Anesthetic Agents, Reversal Drugs, and Toxicity Recognition

CAPA Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & CAPA Exam Strategy

1.1 Current CAPA Exam Facts 1.2 What CAPA Covers vs CPAN 1.3 Eight-to-Fourteen Week CAPA Study Strategy 1.4 Official Resources and Readiness Checklist

2 Anesthesia, Sedation, and Medication Judgment

2.1 Anesthesia Techniques and the Sedation Continuum 2.2 Anesthetic Agents, Reversal Drugs, and Toxicity Recognition 2.3 Preoperative Processes, Consent, and Special Populations 2.4 Positioning, Injury Prevention, Recovery, and Discharge Teaching

3 Physiology, Assessment, and Complication Recognition

3.1 Pre-Admission Screening and Baseline Assessment 3.2 Respiratory, Cardiovascular, and Perfusion Status 3.3 Procedure and Anesthesia Responses Across Body Systems 3.4 Pre-Existing Conditions, Fluids, Electrolytes, and Temperature

4 Perianesthesia Monitoring and Intervention

Hemodynamic Monitoring and Vital-Sign Interpretation Airway, Oxygenation, Ventilation, and Emergence Complications Fluids, Electrolytes, Thermoregulation, and Abnormal Physiologic Conditions Pain, Sedation, Pharmacology, Interactions, and PONV Lines, Drains, Blood Products, Infection Prevention, and Tissue Integrity Ambulatory Safety, Positioning, Environmental Injury Prevention, and Emergency Response

5 Ambulatory Perianesthesia Care Considerations

Continuum, Transfer of Care, and Safe Flow Individualized Care for Ambulatory Special Populations Psychosocial, Environmental, Behavioral Health, and Learning Factors Discharge Readiness, Home Planning, and Resources

6 Professional Practice, Standards, and Final Review

6.1 Professional Standards, Accepted Guidelines, and Team Collaboration 6.2 Evidence-Based Practice and Emergency Guideline Awareness 6.3 Legal, Ethical, Regulatory, and Documentation Accountability 6.4 Final 7-Day Review Plan and Capstone Mixed Practice

2.2 Anesthetic Agents, Reversal Drugs, and Toxicity Recognition

Key Takeaways Explain This Topic AI

Ambulatory anesthesia favors short-acting agents, but short duration never eliminates the need to monitor for respiratory depression, hypotension, nausea, delayed emergence, and recurrent sedation.

Know the reversal target: naloxone reverses opioids, flumazenil reverses benzodiazepines, neostigmine or sugammadex reverse selected nondepolarizing neuromuscular blockers, and dantrolene treats malignant hyperthermia.

Local anesthetic systemic toxicity can begin with neurologic symptoms and progress to seizures, dysrhythmias, and cardiovascular collapse; early recognition and lipid emulsion readiness are key.

Drug judgment on CAPA is usually scenario based: choose the response that supports oxygenation and circulation first, then treats the specific medication problem.

Last updated: May 2026

Medication judgment, not rote memorization

CAPA pharmacology questions usually place the nurse at the bedside. The stem may describe a patient who is too sleepy, hypoventilating, hypotensive, weak after a block, nauseated, confused, or developing a rare emergency. The correct answer is the one that matches the drug effect and protects the patient while the team intervenes.

Common ambulatory anesthetic agents

Drug or class Why it is used Watch for

Propofol Rapid onset, short duration, smooth emergence, antiemetic tendency Respiratory depression, apnea, hypotension, no analgesia.

Midazolam Anxiolysis, amnesia, sedation Respiratory depression when combined with opioids, prolonged sedation in older adults, paradoxical agitation.

Fentanyl and other opioids Analgesia during and after procedures Respiratory depression, nausea, pruritus, urinary retention, recurrent sedation after reversal.

Ketamine Analgesia and dissociative sedation with relative preservation of airway reflexes Emergence reactions, salivation, hypertension or tachycardia in some patients.

Dexmedetomidine Sedation with limited respiratory depression and some analgesic-sparing effect Bradycardia, hypotension, delayed wakefulness.

Etomidate Hemodynamically stable induction in selected patients Myoclonus, nausea, adrenal suppression concern with repeated/prolonged use.

Volatile agents General anesthesia maintenance Postoperative nausea, airway irritation, malignant hyperthermia trigger in susceptible patients.

Nitrous oxide Analgesic adjunct with rapid offset Expansion of air-filled spaces and diffusion hypoxia if oxygenation is not managed.

Reversal agents: match the antidote to the exposure

Reversal medications can be lifesaving, but they do not replace airway management. If the patient is obstructing or apneic, open the airway, provide oxygen, stimulate, and assist ventilation while the cause is addressed.

Problem Reversal or treatment CAPA cautions

Opioid oversedation or respiratory depression Naloxone Shorter duration than many opioids; monitor for recurrent sedation, pain, sympathetic surge, and withdrawal in opioid-tolerant patients.

Benzodiazepine oversedation Flumazenil Can precipitate seizures in patients with chronic benzodiazepine use or mixed overdoses; monitor for resedation.

Residual nondepolarizing neuromuscular blockade Neostigmine with anticholinergic co-medication or sugammadex for rocuronium/vecuronium Persistent weakness can impair ventilation and airway protection; use objective assessment per facility practice.

Malignant hyperthermia Stop triggers, call for help, dantrolene, active cooling, correct acidosis/hyperkalemia Rigidity, rising carbon dioxide, tachycardia, hyperthermia, acidosis, and hyperkalemia are emergency clues.

Local anesthetic systemic toxicity Stop injection, airway/oxygenation support, seizure control, lipid emulsion, cardiovascular support Early neurologic symptoms can precede cardiovascular collapse.

Local anesthetic duration and dose thinking

Local anesthetics differ by onset, duration, potency, and cardiotoxicity. CAPA questions rarely require a full pharmacology table, but they do expect recognition of short-acting versus long-acting choices and toxicity risk.

Agent Common role Practical point

Lidocaine Local infiltration, topical, short procedures Fast onset and shorter duration; epinephrine may prolong effect and reduce systemic absorption.

Mepivacaine Peripheral nerve blocks and infiltration Intermediate duration; less vasodilation than lidocaine.

Bupivacaine Peripheral nerve blocks and longer postoperative analgesia Long duration; higher cardiotoxicity concern if systemic toxicity occurs.

Ropivacaine Peripheral nerve blocks, postoperative analgesia Long acting with less motor block tendency than bupivacaine in some uses, but toxicity is still possible.

Local anesthetic systemic toxicity (LAST) may begin with circumoral numbness, metallic taste, tinnitus, dizziness, agitation, confusion, or tremor. It can progress to seizures, bradycardia, ventricular dysrhythmias, hypotension, and cardiac arrest. The nurse should stop administration if occurring in the nurse's scope, call for help, support oxygenation and ventilation, prepare lipid emulsion according to protocol, and anticipate seizure and cardiovascular management.

Highly vascular injection sites, large total doses, accidental intravascular injection, extremes of age, pregnancy, low muscle mass, hepatic dysfunction, and cardiac disease can increase toxicity risk. Epinephrine may reduce systemic absorption and can serve as an intravascular marker, but it does not make excessive dosing safe.

Neuromuscular blockers and residual weakness

Residual blockade matters in ambulatory recovery because the patient may look awake but still be unable to maintain ventilation, clear secretions, or protect the airway. Clues include weak hand grasp, inability to sustain head lift if assessed, shallow breathing, diplopia, difficulty swallowing, and low oxygen saturation despite wakefulness.

Succinylcholine is a depolarizing neuromuscular blocker with rapid onset and short expected duration. A patient with pseudocholinesterase deficiency can have prolonged paralysis and apnea after succinylcholine. Nondepolarizing agents such as rocuronium or vecuronium may be reversed by sugammadex; neostigmine is used for selected nondepolarizing blockade with an anticholinergic to reduce muscarinic effects.

Malignant hyperthermia vs. other emergencies

Malignant hyperthermia is rare but high-stakes. It is associated with susceptible patients exposed to triggering agents such as volatile anesthetics or succinylcholine. Early signs may include unexpected rise in end-tidal carbon dioxide, tachycardia, muscle rigidity, acidosis, hyperkalemia, and later hyperthermia.

Do not confuse malignant hyperthermia with local anesthetic toxicity or routine fever. LAST points toward neurologic symptoms after local anesthetic exposure and dysrhythmias or seizures. Malignant hyperthermia points toward hypermetabolism after triggering general anesthetics, with dantrolene as the specific treatment.

Recovery implications of reversal

A patient who receives a reversal agent is not automatically ready for discharge. Naloxone and flumazenil may wear off before the sedative or opioid does. Reversal can also unmask pain, agitation, hypertension, nausea, or withdrawal. The patient needs continued monitoring until ventilation, oxygen saturation, mental status, pain control, and vital signs remain stable without repeated rescue.

For exam purposes, choose answers that respect the ABCs first. Medication reversal is appropriate when indicated, but it is usually paired with airway support, team notification, monitoring, and reassessment.